Patient Blood Management
A Global Strategic Business Report
MCP22467
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (281)
13
CXO48
VICE PRESIDENT62
DIRECTOR127
MANAGER31
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Patient Blood Management Market to Reach US$23.6 Billion by 2030
The global market for Patient Blood Management estimated at US$16.1 Billion in the year 2024, is expected to reach US$23.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$10.1 Billion by the end of the analysis period. Growth in the Reagents & Kits segment is estimated at 7.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 9.9% CAGR
The Patient Blood Management market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Global Patient Blood Management Market - Key Trends & Drivers Summarized
Why Is Patient Blood Management Essential in Modern Healthcare?
Patient Blood Management (PBM) has become a crucial component in modern healthcare, providing a systematic approach to optimize the care of patients who might need blood transfusions. PBM focuses on minimizing the need for blood transfusions by managing anemia, reducing blood loss during surgery, and optimizing patients` red blood cell mass, thereby improving clinical outcomes. The importance of PBM lies in its ability to enhance patient safety by reducing the risks associated with transfusions, such as infections, immune reactions, and transfusion-related complications. This evidence-based approach is especially important for patients undergoing surgeries, trauma cases, or those with chronic anemia, as it reduces dependency on blood products and leads to faster recovery.
By minimizing unnecessary transfusions, PBM also plays a significant role in conserving blood supplies, which are often in limited availability. This approach is vital for healthcare systems, particularly in times of blood shortages or in regions with limited access to blood products. With the rising demand for blood due to aging populations and increasing surgical procedures, PBM ensures that blood is available for patients who need it most while encouraging efficient blood use. This practice not only conserves resources but also lowers healthcare costs associated with blood transfusions, making PBM essential for sustainable healthcare management.
Moreover, PBM promotes better overall outcomes by taking a preventive, individualized approach to managing each patient`s blood needs. Through interventions like iron supplementation, erythropoiesis-stimulating agents, and advanced surgical techniques, PBM prepares patients adequately before surgery or treatment. This comprehensive approach reduces the likelihood of complications, shortens hospital stays, and enhances recovery times. As healthcare increasingly emphasizes patient-centered care, PBM provides a tailored, preventive strategy that aligns with modern principles of healthcare delivery, improving both patient satisfaction and health outcomes.
How Are Technological Advancements Enhancing Patient Blood Management?
Technological advancements are significantly enhancing Patient Blood Management by introducing new tools and methods that optimize blood use, minimize blood loss, and improve patient outcomes. One key innovation in PBM is the development of advanced diagnostic tools that allow for early detection and management of anemia before surgery or treatment. Technologies like point-of-care (POC) testing and automated blood analyzers enable rapid hemoglobin assessments and iron deficiency evaluations, allowing healthcare providers to diagnose and treat anemia early. With accurate, real-time diagnostics, clinicians can implement personalized strategies to optimize hemoglobin levels in advance, reducing the likelihood of needing transfusions. These technologies support proactive anemia management, a core component of PBM, ensuring that patients are in the best possible condition before undergoing procedures.
Another major advancement in PBM is the use of cell salvage and blood-sparing surgical techniques, which minimize blood loss and reduce transfusion needs during surgery. Intraoperative cell salvage devices collect and process a patient’s blood during surgery, allowing it to be reinfused back into the patient, thus reducing dependency on donor blood. Additionally, minimally invasive and laparoscopic surgical techniques are becoming increasingly common, as they involve smaller incisions, leading to less blood loss. These techniques are particularly beneficial in high-blood-loss surgeries, such as orthopedic and cardiac procedures. By incorporating cell salvage and minimally invasive techniques, PBM reduces the need for external blood, improving surgical outcomes and supporting resource efficiency.
Pharmaceutical innovations, such as erythropoiesis-stimulating agents (ESAs) and iron supplements, are also playing a critical role in PBM by boosting red blood cell production and addressing anemia without the need for transfusions. ESAs stimulate the bone marrow to produce more red blood cells, which is especially beneficial for patients with chronic anemia or those undergoing chemotherapy. Iron supplements, whether oral or intravenous, support hemoglobin optimization, preparing patients for procedures that may involve blood loss. With these pharmaceutical interventions, PBM offers non-transfusion options for managing anemia, aligning with its goal to enhance patient health while minimizing transfusion requirements. These therapies empower clinicians to tailor PBM strategies to each patient’s needs, providing a more effective and less invasive approach to blood management.
What Are the Benefits of Patient Blood Management for Patients and Healthcare Providers?
Patient Blood Management provides significant benefits for both patients and healthcare providers, improving patient outcomes, reducing healthcare costs, and optimizing the use of limited blood supplies. For patients, PBM enhances safety by minimizing the risks associated with blood transfusions, such as infections, transfusion reactions, and immunologic complications. By employing non-transfusion interventions like anemia management, surgical blood-sparing techniques, and the use of patient’s own blood, PBM reduces the potential for adverse reactions and promotes a safer healthcare experience. For patients undergoing major surgeries, PBM offers the assurance of a carefully managed blood strategy that prioritizes their health, reduces the need for transfusions, and leads to quicker recovery times and shorter hospital stays.
For healthcare providers, PBM supports efficient and sustainable resource management by reducing reliance on donor blood, which is often in limited supply. With blood donation rates unable to keep pace with increasing demand, PBM helps preserve blood resources for patients with critical needs, such as trauma or severe bleeding cases. By reducing blood usage through optimized care and non-transfusion interventions, healthcare providers can manage resources more effectively, lowering the risk of blood shortages and ensuring that blood products are available when truly necessary. PBM also decreases costs associated with blood transfusions, including storage, screening, and administration expenses. This cost-efficiency is especially valuable in large hospitals and health systems, where managing blood resources effectively can lead to substantial financial savings.
Enhanced patient outcomes and quality of care are additional benefits of PBM, as it fosters a more patient-centered, individualized approach to healthcare. Through early anemia detection, blood-sparing surgical practices, and non-transfusion options, PBM enables healthcare providers to create personalized care plans tailored to each patient’s needs. This customized approach reduces the likelihood of complications and supports faster recoveries, improving patient satisfaction and overall quality of care. By proactively managing patients’ blood health, PBM minimizes hospital stays and readmissions, leading to a more streamlined healthcare experience. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting the goal of high-quality, cost-effective, and patient-centered care.
What Is Fueling the Growth in the Patient Blood Management Market?
The growth in the Patient Blood Management market is driven by the rising awareness of transfusion-related risks, increasing surgical and chronic disease cases, advancements in diagnostic and therapeutic technologies, and supportive regulatory policies promoting PBM adoption. As awareness grows around the risks and complications associated with blood transfusions, healthcare providers are increasingly seeking safer and more effective alternatives to traditional transfusion practices. Concerns over infections, immunologic reactions, and potential complications have highlighted the need for PBM programs that minimize transfusions and provide safer care options. This shift in clinical perspective has encouraged more hospitals and healthcare facilities to adopt PBM protocols, driving demand for technologies and practices that support comprehensive blood management.
Increasing numbers of surgeries and the rising prevalence of chronic diseases, such as cancer, kidney disease, and cardiovascular conditions, are also fueling the demand for PBM solutions. With these conditions often requiring surgical interventions or frequent hospitalizations, healthcare providers need effective blood management strategies to support patient care while reducing transfusion dependency. PBM protocols are particularly valuable in high-blood-loss surgeries, as they optimize patient blood health before and during procedures, decreasing the need for transfusions. As the volume of surgeries and hospitalizations continues to grow, so does the demand for effective PBM solutions to manage blood efficiently and improve patient outcomes.
Advancements in diagnostic and therapeutic technologies are significantly contributing to PBM market growth, as they enable more precise, effective, and personalized blood management strategies. New diagnostic tools, such as point-of-care testing and advanced anemia screening, allow for early intervention and accurate management of patient blood levels. Surgical innovations, including cell salvage devices and minimally invasive techniques, reduce blood loss during procedures, minimizing the need for donor blood. Pharmaceutical advancements, such as erythropoiesis-stimulating agents and intravenous iron supplements, provide non-transfusion treatment options for patients with anemia. These technological innovations make PBM programs more accessible and effective, supporting their adoption in hospitals and healthcare facilities worldwide.
Supportive regulatory policies and guidelines are also driving growth in the PBM market, as healthcare organizations and governments recognize the value of PBM in improving patient safety and optimizing blood resources. Regulatory bodies like the World Health Organization (WHO) and health ministries in several countries are encouraging healthcare providers to adopt PBM practices as part of their standard care protocols. Many healthcare systems now require hospitals to implement PBM strategies to comply with quality standards, reduce healthcare costs, and conserve blood resources. Additionally, patient advocacy groups and health organizations have increased educational efforts to promote awareness of PBM benefits among healthcare professionals and the public. These regulatory and advocacy efforts are expanding the adoption of PBM, driving significant growth in the market as providers align with best practices and compliance standards.
Together, these factors—awareness of transfusion risks, increasing surgical and chronic disease prevalence, technological advancements, and supportive regulatory frameworks—are driving robust growth in the Patient Blood Management market. As healthcare systems aim to provide safer, more cost-effective, and resource-efficient care, PBM is becoming a cornerstone of modern, patient-centered healthcare delivery.
SCOPE OF STUDY
The report analyzes the Patient Blood Management market by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Instruments, Reagents & Kits, Software, Accessories); Component (Whole Blood & Red Blood Cells, Plasma); End-Use (Blood Banks, Hospitals).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Abbott Laboratories; Asahi Kasei Medical Co. Ltd.; B. Braun Melsungen AG; Biomérieux SA; Bio-Rad Laboratories, Inc.; Danaher Corporation; F. Hoffmann-La Roche LTD.; Fresenius Se & Co. KGaA; Grifols, S.A.; Haemonetics Corporation; Immucor, Inc.; Kaneka Corporation; Livanova PLC; Macopharma; Terumo Corporation
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Global Economic Update |
| Patient Blood Management – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Focus on Blood Conservation Drives Demand for Patient Blood Management (PBM) Solutions |
| Rising Incidence of Chronic Diseases Expands Addressable Market for PBM |
| Advancements in Blood Transfusion Technologies Propel Market Growth |
| Growing Use of Point-of-Care Hemoglobin Testing Drives PBM Solutions |
| Patient Blood Management Crucial for Enhancing Surgical Outcomes |
| Use of AI for Blood Utilization Optimization Sets the Stage for PBM Growth |
| Increasing Demand for Bloodless Surgery Expands PBM Applications |
| Innovations in Anemia Management Propel PBM Market Expansion |
| Focus on Reducing Blood Transfusion-Related Risks Drives PBM Adoption |
| Use of PBM in Oncology Care Expands Market Opportunities |
| Growing Adoption in Emergency and Trauma Care Expands PBM Applications |
| Use of PBM in Geriatric Care Strengthens Market Opportunities |
| Strategic Investments in Automated Blood Management Solutions Propel PBM Growth |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Whole Blood & Red Blood Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Patient Blood Management Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| JAPAN |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| CHINA |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| EUROPE |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| FRANCE |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| GERMANY |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| INDIA |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
| AFRICA |
| Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]